Hospital Germans Trias i Pujol

Barcelona, Badalona 08916

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia, HER2 Exon 20 Mutation, Non-squamous NSCLC, Psoriasis, Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia

Studies at this site

• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed
• A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) — Stopped early
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed